533212 Stock Overview
GKB Ophthalmics Limited engages in manufacture and sale of unfinished ophthalmic lenses in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
GKB Ophthalmics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹108.10 |
| 52 Week High | ₹136.40 |
| 52 Week Low | ₹74.10 |
| Beta | 0.58 |
| 1 Month Change | 7.68% |
| 3 Month Change | 17.97% |
| 1 Year Change | 8.53% |
| 3 Year Change | 55.09% |
| 5 Year Change | 26.43% |
| Change since IPO | 52.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 533212 | IN Medical Equipment | IN Market | |
|---|---|---|---|
| 7D | -11.7% | -2.7% | -2.0% |
| 1Y | 8.5% | 58.1% | 41.1% |
Return vs Industry: 533212 underperformed the Indian Medical Equipment industry which returned 58.1% over the past year.
Return vs Market: 533212 underperformed the Indian Market which returned 41.1% over the past year.
Price Volatility
| 533212 volatility | |
|---|---|
| 533212 Average Weekly Movement | 10.3% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 533212's share price has been volatile over the past 3 months.
Volatility Over Time: 533212's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 179 | Krishna Gupta | gkb.net |
GKB Ophthalmics Limited engages in manufacture and sale of unfinished ophthalmic lenses in India and internationally. The company provides semi-finished organic lenses, which includes single vision, bifocal, progressive, and aspheric. It exports its products.
GKB Ophthalmics Limited Fundamentals Summary
| 533212 fundamental statistics | |
|---|---|
| Market cap | ₹544.89m |
| Earnings (TTM) | -₹38.14m |
| Revenue (TTM) | ₹866.59m |
0.6x
P/S Ratio-14.3x
P/E RatioIs 533212 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 533212 income statement (TTM) | |
|---|---|
| Revenue | ₹866.59m |
| Cost of Revenue | ₹601.14m |
| Gross Profit | ₹265.45m |
| Other Expenses | ₹303.59m |
| Earnings | -₹38.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | -7.57 |
| Gross Margin | 30.63% |
| Net Profit Margin | -4.40% |
| Debt/Equity Ratio | 16.8% |
How did 533212 perform over the long term?
See historical performance and comparison